doi:10.5301/jn.5000077
Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising new type 2 diabetes and weight management treatment
1.1 Expanded indications and increasing disease prevalence In addition to type 2 diabetes and weight management as key battlegrounds today, GLP-1 therapies have shown clinical promise in treating a wider array of conditions, including Alzheimers disease, cardiovascular risk reduction , MASH (metabolic dysfunction-associated steatohepatitis) and chronic kidney disease (CKD)
If needed, the syringe can be kept from 8C to 30C (46F to 86F) up to 28 days
More recently, researchers have also investigated AOD9604 in the context of cartilage and joint biology
A cascade synergetic strategy induced by photothermal effect based on platelet exosome nanoparticles for tumor therapy